Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Clinical Trial 23482

Salt Lake City, UT 84102


Study Summary:

Despite currently available treatments for dyslipidemia, many patients do not reach therapeutic LDL-C goals and others sustain major CV events, even while being treated with adequate doses of medication. LDL-C lowering by inhibiting the action of proprotein convertase subtilisin kexin type 9 (PCSK9) appears to be a promising new dyslipidemia treatment.


Qualified Participants Must:

• Be 18 years of age, or older
• Have an LDL (“bad cholesterol”) value between 70-100
• Have some form of cardiovascular risk or disease
• Be taking Lipitor, Zocor or Crestor for high cholesterol


Qualified Participants May Receive:

Receive $50.00 per visit
Study medications provided.
No cost to participate
No insurance needed
No change in your doctor
Completely voluntary, no obligation to continue.


Research Site Profile

View Clinic Profile